Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus

Faculty Pharmacy Year: 2016
Type of Publication: ZU Hosted Pages:
Authors:
Journal: PLOS ONE PLOS ONE Volume:
Keywords : Alpha , Antitrypsin Inhibits Dendritic Cell Activation , Attenuates    
Abstract:
Systemic lupus erythematosus (SLE) is an autoimmune disorder with a worldwide distribution and considerable mortality and morbidity. Although the pathogenesis of this disease remains elusive, over-reactive dendritic cells (DCs) play a cri
   
     
 
       

Author Related Publications

  • Hanaa Abdelfattah Attia Elghamry, "Brucine‑Loaded Ethosomal Gel: Design, Optimization, and Anti‑inflammatory Activity", Springer, 2021 More
  • Hanaa Abdelfattah Attia Elghamry, "Quality by Design for Optimizing a Novel Liposomal Jojoba Oil-Based Emulgel to Ameliorate the Anti-Inflammatory Effect of Brucine", MDPI, 2021 More
  • Hanaa Abdelfattah Attia Elghamry, "Purification and biological evaluation of radioiodinated clozapine as possible brain imaging agent", Springer, 2015 More
  • Hanaa Abdelfattah Attia Elghamry, "Fast disintegrating tablet of Valsartan for the treatment of pediatric hypertension: In vitro and in vivo evaluation", Elsevier, 2018 More
  • Hanaa Abdelfattah Attia Elghamry, "Formulation, In Vitro Optimization and In Vivo Evaluation of Sustained Release Transdermal Patches of Venlafaxine Hydrochloride", Latin American Journal of Pharmacy, 2017 More

Department Related Publications

  • Tamer Mohamed Sayed Ahmed Shehata, "Hydrogels and Their Combination with Liposomes, Niosomes, or Transfersomes for Dermal and Transdermal Drug Delivery", InTechOpen, 2017 More
  • Amr Selim Ahmed Ali Abu Lila, "Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model", Wiely, 2017 More
  • Fakhreldeen Soliman Ghazy Shehata, "Solid dispersion approach for optimized bioavailability of sulpiride", Lat.Am.j.Pharm, 2013 More
  • Nagia] Ahmed Alameen Elmgrab, "A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases", european journal of pharmaceutical sciencesl, 2024 More
Tweet